Microbiology 3- Hospital acquired infection and antibiotic resistance Flashcards
Identify bacteria which are multi drug resistant, classifying them by gram- (6) or gram + (5)
Gram-negative: Pseudomonas aeruginosa E. Coli (ESBL) Klebsiella spp (NDM-1) Salmonella spp. (MDR) Acinetobacter baumannii (MDRAB) Neisseria gonorrhoeae
Gram positive: Staphylococcus aureus (MRSA, VISA) Streptococcus pneumoniae Clostridium difficle Enterococcus spp (VRE) Mycobacterium tuberculosis (MDRTB, XDRTB)
List reasons for high rate of hospital acquired infections (6)
High density of suceptiable people
Presence of pathogens
Staff vectors
Open wounds
Inserted medical devices
disruption of normal flora due to antibitotic prophylaxis/ttherapy
Describe the action of Beta-Lactams and give two examples of AB that use this action
Interfere with synthesis of the PEPTIDOGLYCAN component of the bacterial cell wall
Binds to Penicillin Binding Proteins (PBP) - they catalyse a number of steps in peptidoglycan synthesis
The beta-lactam ring is similar in structure to a precursor of peptidoglycan - interferes with the biosynthetic pathway of peptidoglycan
Examples: Penicillin and methicillin
NOTE: MRSA has a different PBP (PBP2a) which doesn’t bind with high affinity to beta-lactams
Describe the action of tertacyline
Inhibits PROTEIN SYNTHESIS
Binds to the 16S component of the 30S ribosomal subunit thus preventing charged aminoacyl tRNAs from binding to the mRNA/ribosome complex
Prevents elongation of the polypeptide
Describe the action of Chloramphenicol
Inhibits protein synthesis.
Binds to 50S ribosomal subunit and blocks peptidyl transfer step.
Often used topically due to toxicity. However, increasing AB resistance is renewing interest in Chloramphenicol as a systemic therapeutic.
Describe the action of Quinolones
Bactericidal - broad spectrum
Targets DNA gyrase (in Gram NEGATIVE) and topoisomerase (in Gram POSITIVE)
DNA gyrase and topoisomerase is responsible for unravelling DNA
Describe the action Sulphonamides
Used to treat UTI, Reproductive Tract Infection (RTI) and bacteraemia
Interferes with the folate pathway
Describe the action of Aminoglycosides and give two examples
Bactericidal
Affect PROTEIN SYNTHESIS
Affects RNA PROOFREADING which leads to misfolded proteins
Some of these proteins are incorporated into the membrane and allow leakage so the cells rupture.
Has toxicity issues
EXAMPLES: Gentamycin, Streptomycin
Describe the action of Macrolides
Gram POSITIVE infections
Targets 50S ribosomal subunit preventing aminoacyl transfer
Causes truncation of polypeptides
EXAMPLE: Erythromycin
What are the 4 mechanisms of antibiotic resistance
Altered target site.
Inactivation of antibiotic.
Altered metabolism.
Decreased drug accumulation.
Describe how altered target site can cause AB resistance
Can arise via acquisition of alternative gene or a gene that encodes a target-modifying enzyme.
Methicillin-resistant Staphylococcus aureus (MRSA) encodes an alternative PBP (PBP2a) with low affinity for beta-lactams.
Streptococcus pneumoniae resistance to erythromycin occurs via the acquisition of the erm gene, which encodes an enzyme that methylates the AB target site in the 50S ribosomal subunit.
Describe how inactivation of antibiotic can cause AB resistance
Enzymatic degradation or alteration, rendering antibiotic ineffective.
Examples include beta-lactamase (bla) and chloramphenicol acetyl-transferase (cat).
ESBL and NDM-1 are examples of broad-spectrum beta-lactamases (can degrade a wide range of beta-lactams, including newest).
Describe how Altered metabolism can cause AB resistance
Re-engineer the metabolic pathways so you bypass the step that the antibiotic interferes with.
Increased production of enzyme substrate can be used to outcompete antibiotic inhibitor
EXAMPLE: increased production of PABA confers resistance to sulphonamides
Describe how Decreased drug accumulationm can cause AB resistance
Reduced permeability of AB into bacterial cell
Increase EFFLUX of AB out of cell
Drug does not reach sufficient concentration to be effective
Summarise some of the main approaches to prevent drug resistant bacteria
Better prescribing practises
Infection control
Combination therapy
Narrow vs broad spectrum antibiotics